CD44 immunoreactivity in soft-tissue sarcomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 4, Issue 3, 1996, Pages 184-189

  Wang, Helena H ^a   DeYoung, Barry R ^b   Swanson, Paul E ^a   Wick, Mark R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

CD44 receptor; Immunohistochemistry; Sarcomas; Soft tissue tumors

Indexed keywords

HERMES ANTIGEN;

ALVEOLAR SOFT PART SARCOMA; ANGIOSARCOMA; ARTICLE; CLEAR CELL SARCOMA; CONTROLLED STUDY; EPITHELIOID SARCOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALIGNANT FIBROUS HISTIOCYTOMA; NERVE SHEATH TUMOR; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA;

EID: 0029838345     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lesley J, Hyman R, Kincade P. CD44 and its interaction with extracellular matrix. Adv Immunol 1993;54:271-335.
2. Heider K-H, Hofmann M, Horst E, van den Berg F, Ponta H, Herrlich P, Pals SJ. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carciomas and adenomatous polyps. J Cell Biol 1993;120: 227-33.
3. Alho AM, Underhill CB. The hyaluronate receptor is preferentially expressed on proliferating epithelial cells. J Cell Biol 1989;108:1557-65.
4. Picker LJ, Nakache M, Butcher EC. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 1989; 109:927-37.
5. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991;3:347-50.
6. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
7. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991;10:343-8.
8. Stamenkovic I, Amiot M, Pesando JM, Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link family. Cell 1989;56:1057-62.
9. Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993;184:47-63.
10. Jalkanen ST, Joensuu H, Soderstrom KO, Klemi P. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest 1991;87:1835-40.
11. Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer Suppl 1994;8:110-15.
12. Shtivelman E, Bishop JM. Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 1991;11:5446-53.
13. Dall P, Heider KH, Sinn HP, et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 1995;60:471-7.
14. Gunthert U, Hofman M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991;65:13-24.
15. Washington K, Gottfried MR, Telen MJ. Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol 1994;25:1043-9.
16. Dhavalkumar DP, Hale LP, Whichard LP, Radcliff G, Mackay CR, Haynes BF. Expression of CD44 molecules and CD44 ligands during human thymic fetal development: expression of CD44 isoforms is developmentally regulated. Int Immunol 1995;7:277-86.
17. Liao HX, Levesque MC, Patton K, et al. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol 1993;151:6490-9.
18. Albeda SM. Endothelial and epithelial cell adhesion molecules. Am J Respir Cell Mol Biol 1991;4:195-203.
19. Honn KV, Tang DG. Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix. Cancer Metastasis Rev 1992;11:353-75.
20. Ruiz P, Schwarzler C, Gunthert U. CD44 isoforms during differentiation and development. Bioessays 1995;17:17-24.
21. Underhill CB. CD44: The hyaluronan receptor. J Cell Sci 1992;103:293-8.
22. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992;116:1055-62.
23. Terpe HJ, Stark H, Prehm P, Gunthert U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 1994;101:79-89.
24. Culty M, Miyake K, Kincade PW, Silorski E, Butcher EC, Underhill CB. The hyaluronate receptor is a member of the CD44(H-CAM) family of cell surface glycoproteins. J Cell Biol 1990;111:2765-74.
25. Hofman M, Rudy W, Zoller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 1991; 51:5292-7.
26. Gunthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K. Are CD44 variant isoforms involved in human tumor progression? Cancer Surv 1995;24:19-42.
27. Messadi DV, Bertolami CN. CD44 and hyaluronan expression in human cutaneous scar fibroblasts. Am J Pathol 1993; 142:1041-9.
28. Mechtersheimer G. Towards the phenotyping of soft tissue tumors by cell surface molecules. Virchows Archiv A Pathol Anal 1991;419:7-28.
29. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994;180: 53-66.
30. Lacy BE, Underhill CB. The hyaluronate receptor is associated with actin filaments. J Cell Biol 1987;105:1395-1404.
31. Herrlich P, Zoller M, Pals ST, Ponta H. CD44 splice variants: metastases meet lymphocytes. Immunol Today 1993; 14:395-9.
32. Stauder R, Eisterer W, Thaler J, Gunthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995;85:2885-99.
33. Terpe HJ, Koopmann R, Imhof BA, Gunthert U. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas. J Pathol 1994;174:89-100.
34. Mayer B, Jauch KW, Gunthert U, et al. De novo expression of CD44 and survival in gastric cancer. Lancet 1993;342: 1019-22.
35. Terpe HJ, Tajrobehkar K, Gunthert U, Altmannsberger M. Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD44 in renal cell carcinomas: an immunohistochemical study. Virchows Arch A Pathol Anal Histopathol 1993;422:219-24.
36. Joensuu H, Klemi PJ, Toikkanen S, Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 1993;143:867-74.